Venue: COBIS - M13, Ole Maaløes Vej 3, 2200 CPH N
DANSK BIOTEK & MSC Nordics invite you to a workshop discussing financial models for biotech companies to guide business planning, portfolio management and negotiation.
What is your valuation based on? This dreaded question most CEOs, with pre-commercial drugs in their pipelines, hate to answer. Investors and Big Pharma executives of course know that any financial model will be inherently imprecise – yet they want you to present a valuation based on logical and data-driven assumptions.
This workshop, led by MSC Nordics, will go through the basics of why it makes sense to create a financial model for biotech companies to guide business planning, portfolio management and negotiation. We will use real world examples to illustrate best practice and common pitfalls we have experienced together with our life science clients.
Key topics that will be covered include: